RPID
NASDAQ · Life Sciences Tools & Services
Rapid Micro Biosystems Inc-A
$1.10
-0.02 (-1.35%)
Financial Highlights (FY 2026)
Revenue
37.70M
Net Income
-52,903,286
Gross Margin
3.1%
Profit Margin
-140.3%
Rev Growth
+25.2%
D/E Ratio
0.57
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 3.1% | 3.1% | 67.1% | 67.1% |
| Operating Margin | -141.1% | -127.0% | 15.2% | 14.6% |
| Profit Margin | -140.3% | -133.3% | 15.7% | 16.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 37.70M | 30.13M | 48.80M | 45.04M |
| Gross Profit | 1.18M | 939.9K | 32.74M | 30.22M |
| Operating Income | -53,201,670 | -38,256,234 | 7.43M | 6.55M |
| Net Income | -52,903,286 | -38,041,672 | 7.65M | 7.46M |
| Gross Margin | 3.1% | 3.1% | 67.1% | 67.1% |
| Operating Margin | -141.1% | -127.0% | 15.2% | 14.6% |
| Profit Margin | -140.3% | -133.3% | 15.7% | 16.6% |
| Rev Growth | +25.2% | +25.2% | +18.7% | +19.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 10.16M | 10.16M | 38.69M | 38.35M |
| Total Equity | 17.68M | 17.68M | 134.82M | 132.50M |
| D/E Ratio | 0.57 | 0.57 | 0.29 | 0.29 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -49,552,627 | -37,611,853 | 9.93M | 10.62M |
| Free Cash Flow | — | — | 5.64M | 3.34M |